Aripiprazole: the evidence of its therapeutic impact in schizophrenia

INTRODUCTION: An ideal antipsychotic would rapidly stabilize acute psychotic symptoms and maintain the patient, without relapse, for prolonged periods in the absence of extrapyramidal, endocrine, diabetic, or cardiovascular side effects, and without weight gain. The dopamine partial agonist aripipra...

Descripción completa

Detalles Bibliográficos
Autores principales: Winlow, William, Profit, Louise, Chrisp, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2006
Materias:
Clinical Impact Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321669/
https://www.ncbi.nlm.nih.gov/pubmed/22496680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321669/
https://www.ncbi.nlm.nih.gov/pubmed/22496680

Ejemplares similares